local_hospital
verifiedVerified

Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu

Address
lock Available on a paid plan

Immune System Research

At Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu, clinical research is centered on immune system processes, with studies focused on preventing serious viral infections and understanding how the body responds to vaccination.

  • Prevention of respiratory syncytial virus infection in infants and young children
  • Evaluation of the safety and effectiveness of a new approach to RSV prevention

This work is designed to improve protection against early-life respiratory illness and to assess how well preventive strategies are tolerated in a pediatric population.

Pediatric Vaccine Studies

The site also supports research in pediatrics and infectious diseases, with a strong focus on human papillomavirus prevention in boys and girls. These studies look at whether simplified vaccination schedules can generate a strong immune response while maintaining safety.

  • Prevention of persistent anogenital HPV infection
  • Protection against disease caused by multiple HPV types

The research aims to support better vaccination strategies for adolescents and to help clarify how the immune system responds over time after vaccination.

Site Overview

assignment
164
connected trials
corporate_fare
90
sponsors
science
277
IMPs

Activity Indicator

Last 6 months

22
Trials started
+10% vs previous period.
20
Trials started 6–12 months ago
164
Total trials linked
Highly Active
trending_upGrowing+10%
2
4
7
5
4
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 of 21 therapeutic areas and 15 of 277 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 267 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
91
Sponsors (total)
90
Active sponsors
69

Sponsor Network

Top 69 by active trials.

lock +68 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +30 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
164
Outperforms 100% of sites
public
Therapeutic diversity
22areas
Outperforms 100% of sites
groups
Sponsor diversity
90sponsors
Outperforms 100% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu

lock Showing 1 of 164 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter Randomized Non‑Inferiority Trial of Weekly Somatrogon versus Daily Somatropin in Pediatric Patients with Small‑for‑Gestational‑Age or Idiopathic Short StatureSchneider Children's Medical Center Of IsraelPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 277 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Dexamethasone17Unknown2017-10-022026-07-28

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.